Femarelle

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2016
012320032016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
OBJECTIVE To assess the effects of 2 months of treatment with Femarelle for climacteric syndrome in Taiwanese postmenopausal… (More)
Is this relevant?
2011
2011
OBJECTIVE The purpose of this study was to assess the effect of DT56a (Femarelle), a selective estrogen receptor modulator, on… (More)
Is this relevant?
2011
2011
Objective: DT56a (Femarelle ® ) is a natural compound for the treatment of menopausal symptoms and osteoporosis. The aim of this… (More)
Is this relevant?
2009
2009
OBJECTIVE The natural selective estrogen receptor modulator DT56a (Femarelle), derived from soybean, has been shown to relieve… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 4
Is this relevant?
2007
2007
A selective estrogen receptor modulator (SERM) is defined as a substance with dissimilar effects on different tissues: agonist in… (More)
Is this relevant?
2007
2007
The association between hormone replacement therapy (HRT) and breast cancer has been debated since the introduction of this… (More)
Is this relevant?
2005
2005
OBJECTIVE DT56a is a natural compound for the treatment of menopausal symptoms and osteoporosis. The aim of this study was to… (More)
Is this relevant?
2004
2004
OBJECTIVE In a previous study treatment with a daily standard dose of Femarelle (644 mg/day) resulted in a significant elevation… (More)
Is this relevant?
2003
2003
OBJECTIVE To evaluate the efficacy of Tofupill/Femarelle (DT56a), a novel phyto-selective estrogen receptor modulator (SERM), in… (More)
Is this relevant?
2003
2003
The novel natural product DT56a (Tofupill/Femarelle), derived from soybean, has been shown to relieve menopausal vasomotor… (More)
  • figure 1
  • figure 4
  • figure 3
  • figure 5
Is this relevant?